Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1977-06-06
1981-04-21
Ford, John M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
544182, C07D25306, C07D40506, C07D40514, A61K 3153
Patent
active
042632951
ABSTRACT:
Novel triazine compounds useful for treating central nervous system depression and anxiety in a mammal, their method of use and pharmaceutical compositions thereof.
REFERENCES:
patent: 3471485 (1969-10-01), Trepanier
patent: 3471486 (1969-10-01), Trepanier
Trepanier et al., J. of Medicinal Chem., vol. 12, pp. 257-260 (1969).
Spatz David M.
Widner Paul J.
Ford John M.
The Dow Chemical Company
LandOfFree
Psychoactive 3-(1-2-diarylethyl)-1,4,5,6-tetrahydro-1,2,4-triazi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Psychoactive 3-(1-2-diarylethyl)-1,4,5,6-tetrahydro-1,2,4-triazi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Psychoactive 3-(1-2-diarylethyl)-1,4,5,6-tetrahydro-1,2,4-triazi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-557758